Artiva Biotherapeutics, Inc. (ARTV)
6.60
-0.23
(-3.37%)
USD |
NASDAQ |
Oct 05, 09:54
Artiva Biotherapeutics Total Liabilities (Quarterly) : 21.13M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.13M |
| March 31, 2026 | 18.11M |
| December 31, 2025 | 24.60M |
| September 30, 2025 | 19.64M |
| June 30, 2025 | 20.35M |
| March 31, 2025 | 22.48M |
| December 31, 2024 | 22.94M |
| September 30, 2024 | 24.60M |
| June 30, 2024 | 50.60M |
| March 31, 2024 | 48.42M |
| December 31, 2023 | 50.72M |
| September 30, 2023 |
| Date | Value |
|---|---|
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | 44.83M |
| December 31, 2021 | 42.37M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 50.80M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Climb Bio, Inc. | 6.747M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 368.63M |
| Shareholders Equity (Quarterly) | 347.50M |
| Debt to Equity Ratio | 0.0283 |
| Current Ratio | 24.16 |
| Net Debt Paydown Yield | 0.18% |